We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Declines More Than Market: Some Information for Investors
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed at $29.16 in the latest trading session, marking a -2.57% move from the prior day. The stock's change was less than the S&P 500's daily loss of 0.1%. On the other hand, the Dow registered a gain of 0.35%, and the technology-centric Nasdaq decreased by 0.43%.
Prior to today's trading, shares of the company had gained 36.73% outpaced the Finance sector's gain of 2.81% and the S&P 500's loss of 1.34%.
Market participants will be closely following the financial results of Oscar Health, Inc. in its upcoming release. The company is expected to report EPS of $0.34, up 138.2% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $4.83 billion, reflecting a 68.58% rise from the equivalent quarter last year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $0.47 per share and revenue of $18.7 billion, indicating changes of +127.81% and +59.85%, respectively, compared to the previous year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Oscar Health, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Oscar Health, Inc. is holding a Zacks Rank of #3 (Hold) right now.
In the context of valuation, Oscar Health, Inc. is at present trading with a Forward P/E ratio of 63.68. This denotes a premium relative to the industry average Forward P/E of 9.59.
Also, we should mention that OSCR has a PEG ratio of 2.09. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As the market closed yesterday, the Insurance - Multi line industry was having an average PEG ratio of 0.92.
The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 156, finds itself in the bottom 37% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Oscar Health, Inc. (OSCR) Declines More Than Market: Some Information for Investors
Oscar Health, Inc. (OSCR - Free Report) closed at $29.16 in the latest trading session, marking a -2.57% move from the prior day. The stock's change was less than the S&P 500's daily loss of 0.1%. On the other hand, the Dow registered a gain of 0.35%, and the technology-centric Nasdaq decreased by 0.43%.
Prior to today's trading, shares of the company had gained 36.73% outpaced the Finance sector's gain of 2.81% and the S&P 500's loss of 1.34%.
Market participants will be closely following the financial results of Oscar Health, Inc. in its upcoming release. The company is expected to report EPS of $0.34, up 138.2% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $4.83 billion, reflecting a 68.58% rise from the equivalent quarter last year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $0.47 per share and revenue of $18.7 billion, indicating changes of +127.81% and +59.85%, respectively, compared to the previous year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Oscar Health, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Oscar Health, Inc. is holding a Zacks Rank of #3 (Hold) right now.
In the context of valuation, Oscar Health, Inc. is at present trading with a Forward P/E ratio of 63.68. This denotes a premium relative to the industry average Forward P/E of 9.59.
Also, we should mention that OSCR has a PEG ratio of 2.09. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As the market closed yesterday, the Insurance - Multi line industry was having an average PEG ratio of 0.92.
The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 156, finds itself in the bottom 37% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.